XML 71 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity-based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense Stock‑based compensation expense by classification within the consolidated statements of operations and comprehensive income (loss) is as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Research and development

 

$

59,683

 

 

$

35,120

 

 

$

23,273

 

General and administrative

 

 

42,707

 

 

 

30,898

 

 

 

20,784

 

Loss from equity method investment

 

 

 

 

 

 

 

 

5,467

 

Total

 

$

102,390

 

 

$

66,018

 

 

$

49,524

 

 

Fair Value of Each Option Issued to Employees Estimated Using Black-Scholes Option-Pricing Model

The fair value of each option issued to employees was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:

 

 

 

Years Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Options granted

 

 

1,616,255

 

 

 

2,182,773

 

 

 

2,832,784

 

Weighted-average exercise price

 

$

124.32

 

 

$

68.91

 

 

$

39.16

 

Weighted-average grant date fair value

 

$

77.38

 

 

$

42.28

 

 

$

24.57

 

Assumptions:

 

 

 

 

 

 

 

 

 

Expected volatility

 

 

70.3

%

 

 

69.2

%

 

 

68.9

%

Expected term (in years)

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

Risk-free interest rate

 

 

1.0

%

 

 

0.6

%

 

 

2.2

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

Summary of Stock Option Activity

The following table summarizes stock option activity under the Company’s equity award plans (intrinsic value in thousands):

 

 

 

Shares

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2020

 

 

8,101,980

 

 

$

42.44

 

 

 

7.8

 

 

$

896,666

 

Granted

 

 

1,616,255

 

 

$

124.32

 

 

 

 

 

 

 

Exercised

 

 

(1,245,071

)

 

$

30.96

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(660,182

)

 

$

79.54

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

7,812,982

 

 

$

58.07

 

 

 

7.4

 

 

 

219,103

 

Exercisable at December 31, 2021

 

 

4,598,353

 

 

$

40.86

 

 

 

6.6

 

 

$

174,056

 

Vested and expected to vest at December 31, 2021

 

 

7,812,982

 

 

$

58.07

 

 

 

7.4

 

 

$

219,103

 

 

Summary of Restricted Stock Activity

The following table summarizes the restricted stock activity under the Company’s equity award plans:

 

 

 

Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

Unvested balance at December 31, 2020

 

 

894,092

 

 

$

70.55

 

Granted

 

 

628,175

 

 

 

111.73

 

Vested

 

 

(455,440

)

 

 

58.00

 

Cancelled or forfeited

 

 

(132,652

)

 

 

100.25

 

Unvested balance at December 31, 2021

 

 

934,175

 

 

$

100.14